Workflow
灵康药业(603669) - 2017 Q1 - 季度财报
LioncoLionco(SH:603669)2017-04-28 16:00

Financial Performance - Operating revenue for the period was CNY 121,373,673.99, an increase of 18.04% year-on-year [6]. - Net profit attributable to shareholders was CNY 24,281,511.72, reflecting a growth of 15.66% compared to the same period last year [6]. - The company's basic earnings per share increased to CNY 0.11, representing a growth of 10.00% [6]. - Total operating revenue for Q1 2017 was CNY 121,373,673.99, an increase of 17.3% compared to CNY 102,822,206.34 in the same period last year [23]. - Net profit for Q1 2017 reached CNY 28,255,063.18, up 7.3% from CNY 26,334,898.93 in Q1 2016 [24]. - Operating profit for Q1 2017 was CNY 31,569,777.85, slightly down from CNY 32,579,887.33 in the previous year, reflecting a decrease of 3.1% [24]. - Basic earnings per share for Q1 2017 were CNY 0.11, compared to CNY 0.10 in the same period last year, indicating a 10% increase [24]. Cash Flow - The net cash flow from operating activities was CNY 4,926,273.16, a significant decrease of 87.09% year-on-year [6]. - Cash inflow from sales of goods and services was $122,149,188.08, a decrease of 1.8% from $124,355,672.33 in the previous period [29]. - Net cash flow from operating activities was $4,926,273.16, down 87.1% from $38,162,388.70 in the previous period [29]. - Cash inflow from investment activities was $305,472,580.79, a slight decrease of 1.3% from $309,172,797.35 in the previous period [30]. - Net cash flow from investment activities was -$14,085,533.06, compared to $60,525,701.26 in the previous period [30]. - Cash inflow from financing activities was $1,500,000.00, down 25% from $2,000,000.00 in the previous period [33]. - Cash outflow for financing activities was $700,000.00, an increase of 133.3% from $300,000.00 in the previous period [33]. - The net increase in cash and cash equivalents was -$9,159,259.90, compared to an increase of $48,494,889.96 in the previous period [30]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 1,342,481,726.62, a decrease of 0.11% compared to the end of the previous year [6]. - Total assets as of March 31, 2017, were RMB 1,342,481,726.62, slightly down from RMB 1,344,015,471.52 at the beginning of the year [19]. - Total liabilities decreased to RMB 144,776,725.72 from RMB 174,565,533.80, showing a reduction of about 17% [18]. - Total current liabilities decreased to RMB 131,415,644.36 from RMB 160,732,050.76, reflecting a decline of about 18% [18]. - Total liabilities for Q1 2017 were CNY 27,542,905.69, a decrease of 47.6% from CNY 52,609,340.30 in the same period last year [22]. - The company's total equity increased to CNY 1,210,552,715.78 in Q1 2017, up from CNY 1,181,423,000.97 in Q1 2016, representing a growth of 2.5% [22]. Shareholder Information - The number of shareholders at the end of the reporting period was 28,752 [9]. - The company raised a total of RMB 76,050,000 from the issuance of 65 million A-shares at a price of RMB 11.70 per share, with a net amount of RMB 70,294,970 after deducting issuance costs [13]. Expenses and Investments - Sales expenses rose to CNY 29,251,039.62, a substantial increase of 253.45% due to enhanced sales promotion efforts [12]. - The company reported a decrease in government subsidies recognized as operating income, totaling CNY 569,327.34, down 35.46% year-on-year [12]. - The cash paid for acquiring fixed assets and other long-term assets was CNY 19,558,113.85, an increase of 59.70% compared to the previous year [12]. - Operating costs for Q1 2017 were CNY 93,859,584.91, up 24.4% from CNY 75,422,239.65 in Q1 2016 [23]. - The company reported a tax expense of CNY 3,800,759.47 for Q1 2017, down 46.0% from CNY 7,026,245.36 in Q1 2016 [24]. - Investment income for Q1 2017 was CNY 4,055,688.77, a decrease of 21.6% compared to CNY 5,179,920.64 in the previous year [24].